MedPath

Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)

Phase 1
Recruiting
Conditions
novel coronavirus pneumonia (COVID-19)
Registration Number
ITMCTR2000003064
Lead Sponsor
Affiliated Hospital of Changchun University of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Suspected, mild, normal and severe cases diagnosed in accordance with the diagnosis and treatment scheme for pneumonia of novel coronavirus infection (trial version 5);
2. Aged >= 18 years;
3. Patients who voluntarily participate in the study and sign informed consent.

Exclusion Criteria

(1) Known to be allergic to the ingredients contained in the research medication, or patients with allergies;
(2) Unwilling to cooperate with the information collector;
(3) Patients with mental illness, or cognitive impairment;
(4) Women who are breastfeeding or pregnant, or who have a positive urine pregnancy test, or who do not agree to contraception within 3 months of participating in the test;
(5) Other patients that the investigator considers unsuitable to participate in this study

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality Rate;Critically ill patients (%);
Secondary Outcome Measures
NameTimeMethod
The incidence of complications;Imaging absorption of pneumonia;Inhospital time;Time for clinical symptom to disappear;Total cost of treatment;Cure rate of clinical symptoms;Intensive Care Time;
© Copyright 2025. All Rights Reserved by MedPath